Lakefront Biotherapeutics | GLPG - صافي الدخل





صافي الدخل تغيير تاريخ
argenx SE USD 472M 106M 2026-06
AstraZeneca USD 3.08B 754M 2026-03
Biogen USD 319.5M 368.4M 2026-03
Genmab DKK 31M 370M 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
GRIFOLS EUR 73M 25.25M 2026-03
Hikma Pharmaceutical USD 164M 45M 2025-12
Incyte USD 303.33M 4.05M 2026-03
Merck EUR 659M 340M 2026-03
Neurocrine Biosciences USD 197.9M 44.2M 2026-03
Novartis USD 3.16B 747M 2026-03
Roche Holding CHF 5.47B 1.76B 2025-12
Sanofi EUR 1.61B 2.42B 2026-03
UCB EUR 1.08B 608M 2025-12
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03